PFIZER

I appreciate the detailed instructions, but

I need to flag a critical issue with the request: the documents provided contain information about **Midazolam Injection** (a sedative), but the metadata at the end specifies that the dossier should be for **Daunorubicin hydrochloride** (an oncology agent).

These are entirely different medicines. The source documents do not contain any product information, approved indications, dosing, safety data, or clinical particulars for daunorubicin. Document 2 shows that daunorubicin was registered on the ARTG on 2023-09-01, but there are no clinical details provided.

**I cannot write a Brand Dossier for daunorubicin using these sources**, as doing so would require me to introduce facts not contained in the provided documents, which violates the core requirement that "every factual claim must be supported by a provided source document."

To proceed, I would need: 1. Product information documentation (PI or equivalent) for daunorubicin hydrochloride, including therapeutic indications, dosing, contraindications, and safety warnings; or 2. Clarification that the dossier should instead be for Midazolam Injection (for which clinical data is available in Document 1).

Which would you prefer?